Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aquinox raises $25 million for pipeline in series B financing

This article was originally published in Scrip

Executive Summary

Aquinox Pharmaceuticals, a Canadian biopharmaceutical company developing targeted small-molecule therapeutics for the treatment of inflammatory diseases and cancer, has completed a $25 million series B financing that will enable the company to move its lead drug candidate, AQX-1125, into Phase I and II clinical trials.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC009213

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel